Efficacy and Safety of the Association of Nimodipine and Choline Alphoscerate in the Treatment of Cognitive Impairment in Patients with Cerebral Small Vessel Disease. The CONIVaD Trial.

Emilia SalvadoriAnna PoggesiIda DonniniValentina RinnociGuido ChitiMartina SquitieriLaura TudiscoFabio FieriniAnna MeloneFrancesca PesciniLeonardo Pantoni

Published in: Drugs & aging (2021)

Clinical Trial NCT03228498. Registered 25 July 2017.

Keyphrases

clinical trial
cognitive impairment
subarachnoid hemorrhage
phase ii
study protocol
phase iii
open label
cerebral blood flow
smoking cessation